Behold the deluge. The Centers for Medicare and Medicaid Services’ (CMS) proposal last month to restrict Aduhelm coverage to clinical trials stirred up such strong feelings on both sides that the usual 30-day public comment period following every CMS.....
There's a growing awareness of the many reasons people of color experience poor health outcomes, including the stresses of racism itself. But one area of racial health disparity isn't often discussed: the lack of equitable access to prescription drugs....
For Oregonians hit hardest by the pandemic, President Biden's Build Back Better legislation could send the help desperately needed by far too many poor and underserved communities. ...
The COVID-19 pandemic magnified longstanding gaps in health outcomes for underserved communities. Amy Hinojosa, President and CEO of MANA, A National Latina Organization, joins host Tetiana Anderson representing the Health Equity Collaborative, which was formed in response to the pandemic’s impact on minority populations, to...
Black Americans have been hit hardest by COVID-19. Yet we’re also much less likely to take the vaccines. In the District of Columbia, for example, Blacks account for 55% of all COVID-19 cases and 70% of all deaths, yet have received only 40% of vaccinations....
Eleven years ago, Congress passed the Affordable Care Act and began the largest expansion of access to health care in this country in five decades. This landmark law gave 20 million previously uninsured Americans access to health care. But that was not all....
A coalition of more than 30 civil rights, progressive and multicultural groups is appealing to the Biden administration and lawmakers on the Hill to adopt their policy guidelines and “engage directly with community-based organizations and public health advocates when developing interventions to measurably improve health...
Cision - Today, a coalition of 33 progressive, civil rights, and multicultural organizations sent a letter to Congress and the Biden administration outlining new guidelines to elevate health equity....
Black and Latino patients have far less access to potentially life-saving experimental drugs than white Americans. As the Biden administration and research industry address the COVID-19 pandemic and plan for the next one, they must make health equity a priority in our nation's drug development...
Underrepresentation is a big problem for minority patients on an individual level. Clinical trial participants get to take life-saving treatments years before those medicines become available to the public....
The Centers for Medicare & Medicaid Services (CMS) just took an important step towards addressing one of the worst public health crises of our time. No, not COVID-19, but a disease that chronically affects millions of Americans: diabetes. ...
A newly released study by the Institute for Clinical and Economic Review, a Boston-based nonprofit, attempts to answer a weighty question: How much should it cost to treat the novel coronavirus?...